StonvexLoading…
StonvexStonvexStonvexCore line items from STRL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.49B | $2.12B | $1.97B | $1.77B |
Operating Income | $405.92M | $264.62M | $205.79M | $159.87M |
Net Income | $290.15M | $257.46M | $138.66M | $106.46M |
EPS (Diluted) | $9.38 | $8.27 | $4.44 | $3.48 |
Total Assets | $2.63B | $2.02B | $1.78B | $1.44B |
Total Liabilities | $1.53B | $1.19B | $1.15B | $963.82M |
Cash & Equivalents | $390.72M | $664.20M | $471.56M | $181.54M |
Free Cash Flow OCF − CapEx | $362.68M | $416.15M | $414.20M | $158.21M |
Shares Outstanding | 30.68M | 30.67M | 30.93M | 30.59M |